Description: Globally, co-circulation of SARS-CoV-2, influenza and respiratory syncytial virus (RSV) was observed during the 2022 respiratory season with the easing of COVID-19 measures. This led to increased burden on healthcare infrastructure and increased risk of severe illness for high-risk populations.1,2Rapid testing to facilitate early diagnosis of high-risk patient populations and adoption of respiratory multiplexed tests with the integration of SARS-CoV-2 testing are required.5Ensure the accuracy of test performance despite new SARS-CoV-2 variants4 and influenza A mutations.3Rapid testing results to facilitate early diagnosis for effective patient management.5Multiplexing ability for the most prevalent and actionable pathogens (SARS-CoV-2, influenza A, influenza B, RSV) to simplify the diagnosis process.Lot # 1001449361
Price: 400 USD
Location: Clifton, New Jersey
End Time: 2024-12-01T17:21:56.000Z
Shipping Cost: N/A USD
Product Images
Item Specifics
All returns accepted: ReturnsNotAccepted
Brand: Cepheid
Expiration Date: 09-21-2025
Unit Type: Unit
Model: Xpress CoV-2/Flu/RSV plus
MPN: Xpress CoV-2/Flu/RSV plus
Country/Region of Manufacture: United States
Unit Quantity: 10
